Natus Medical Incorp secures last-minute Real Value of $48.53 per share. The latest price of the firm is $40.1. At this time the firm appears to be under valued. Macroaxis forecasts value of Natus Medical Incorp from analyzing the firm fundamentals such as Current Valuation of 1.25B, Profit Margin of
4.23% and Return On Equity of 4.58% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
Valuation Drivers Correlation
|Investment Horizon||30 Days Login to change|
Natus Medical Incorporated is number one stock in price to earning category among related companies. It is rated second in beta category among related companies totaling about 0.02 of Beta per Price to Earning. The ratio of Price to Earning to Beta for Natus Medical Incorporated is roughly 64.95
Natus Medical is not too risky asset. Calculation of real value of Natus Medical Incorp is based on 1 month time horizon. Increasing Natus Medical Incorp time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.